Slide 1: Financial Results - 9M 2025
Financial Results - 9M 2025 Titan Group Investors’ & Analysts’ Presentation Athens, 6 November 2025
Slide 2: Q3 2025 Results
Q3 2025 Results
Slide 3: 2025 Q3 & YTD Highlights – Strong performance and positive outlook
2025 Q3 & YTD Highlights – Strong performance and positive outlook Sales EBITDA • €684m in Q3’25 vs. €662m in Q3’24; +3.4% • €187m in Q3’25 vs. €156m in Q3’24; +19.9% • €2,013m YTD’25 vs. €1,985m YTD’24; +1.4% • €474m YTD’25 vs. €437m YTD’24; +8.4% NOPAT / EPS Liquidity / Leverage ratio • €102m in Q
Slide 4: Robust sales and profitability growth in Q3
Robust sales and profitability growth in Q3 Group Sales (€m) Group EBITDA (€m) Group NPAT (€m) 1,500 300 300 +19.9% 1,000 +3.4% 200 31.0 186.6 200 155.6 Q3 2025 22.4 +35.0% 661.6 684.0 26.5 102.4 500 100 100 75.9 0 0 0 2024 Variance 2025 2024 Variance 2025 2024 Variance 2025 23.5% EBITDA Margin 27.3
Slide 5: Sustained 12-month rolling growth trajectory
Sustained 12-month rolling growth trajectory Group Sales (€m) Group EBITDA (€m) Group NPAT (€m)* +2.8% 4,500 900 295.6 8.4 304.0 +6.2% 300 16.7 +1.2% 36.1 616.7 51.9 3,000 600 580.6 2,639.3 32.8 2,672.1 * 12-Month Rolling 150 1,500 300 235.4 0 0 0 12MR Variance 12MR 12MR Variance 12MR 12MR Variance
Slide 6: Group Income Statement – 9M 2025
Group Income Statement – 9M 2025 *Adjusted NPAT excluding scope change due to the sale of Adocim in May 2025 (€51.9m) 9M 2025 Results – Investors’ & Analysts’ Presentation 6
Slide 7: Sales Volume performance
Sales Volume performance 9M 2025 Sales Volume Q3 2025 Sales Volume Excluding Excluding 2024 2025 Adocim Adocim +2% +5% -1% -2% 13.4 4.7 4.6 13.2 +4% 4.7 4.9 +11% 17.7 +2% 15.9 +7% 1.6 1.6 5.7 6.1 0.9 0.8 0.2 0.3 Cement 3rd Party Aggregates Ready-mix Cement 3rd Party Aggregates Ready-mix Domestic Cem
Slide 8: Serving flagship customer projects with our products and materials
Serving flagship customer projects with our products and materials Riviera Galleria, The Ellinikon, Greece QTS Data centers, Virginia, USA Signature Miami Bridge, Florida, USA Thessaloniki Flyover, Greece 8 9M 2025 Results – Investors’ & Analysts’ Presentation
Slide 9: CapEx at €185m focused on key strategic priorities
CapEx at €185m focused on key strategic priorities 2025 CapEx (€m) Major 2025 CapEx Projects 115.0 USA USA 106.4 • Roanoke plant: Quarry Expansion • Cement Type 1T development • Mixer Trucks 37.5 GREECE • Ready-Mix Fixed & Portable Plants 45.6 • Block Plants • Logistics 2025 16.2 SEE 2024 Greece & W
Slide 10: Operating Free Cash Flow at €307m in 9M 2025
Operating Free Cash Flow at €307m in 9M 2025 Net Debt decreased by €320m to €302m. 2025 Operating Free Cash Flow €307 m 412 (237) 22 (110) 474 (79) 23 320 (185) EBITDA 2025 Non-Cash Operating Finance CapEx Disposals Dividend, FX Impact Decrease in Items WC & Tax (Net) Share Buybacks on Net Debt Net
Slide 11: Debt and Liquidity Profile - September 2025
Debt and Liquidity Profile - 30 September 2025 Group Net and Gross Debt Evolution Maturity Profile (€m) 1,200 Net Debt/ EBITDA ratio at 0.5x 6 >80% of Debt is long-term Gross Debt Bank Debt 1,000 Net Debt Bond 934 5 882 903 902 Net Debt/EBITDA Leases 869 853 867 861 870 827 912 428 800 838 745 728 4
Slide 12: Overview of Markets Performance
Overview of Markets Performance
Slide 13: US Solid performance
US Solid performance USA YTD Sales (€ m) • US delivered a strong performance in Q3, driven by continued operational excellence, 1,500 -1.9% efficiencies & synergies from targeted investments in recent years. 1,151.3 -22.2 1,129.1 • Volumes in cement, Ready-Mix, aggregates & fly ash all increased in
Slide 14: In Greece growth continued across all products
In Greece growth continued across all products Greece & W. Europe YTD Sales (€ m) 600 • The Greek domestic market continued to perform robustly, maintaining the strong +14.7% momentum seen throughout the year. 49.2 384.8 400 335.5 • Cement consumption grew by ~10%, with cement sales outperforming th
Slide 15: SEE performance bounced back in Q3 2025
SEE performance bounced back in Q3 2025 SEE YTD Sales (€ m) 600 • Market conditions across SE Europe remained broadly stable throughout the year. Following exceptionally strong volumes in the early months of 2024, which created a -0.7% high comparison base, market activity has since normalized. 400
Slide 16: Strong growth in EMED following turnaround results in Egypt
Strong growth in EMED following turnaround results in Egypt E.MED. YTD Sales (€ m) • Egypt continued on the growth path started this year, capitalizing on both robust domestic 300 demand and its growing role as a key exporter. +1.7% • Higher domestic and export volumes, combined with improved pricin
Slide 17: Brazil - Joint Venture: Cimento Apodi profitability improves
Brazil - Joint Venture: Cimento Apodi profitability improves YTD 2025 Apodi (100%) In million Euro 2025 2024 Sales 78.3 81.7 EBITDA 20.3 18.1 * Consolidated on an equity basis • Domestic cement consumption in Brazil grew by 3.0% in the nine months of 2025. • In the Northeast region, where we operate
Slide 18: Outlook
= ° ° = S 1e)
Slide 19: Outlook
Outlook The outlook for the remainder of the year is positive, supported by solid backlog growth across products, resilient pricing, cost initiatives and efficiency gains. For 2026, Titan is well-positioned to deliver top-line growth, stronger margins and shareholder value, driven by continuous inve
Slide 20: APPENDIX
ve Ie ~~ APPENDIX eg ee.
Slide 21: Group Balance Sheet – 9M 2025
Group Balance Sheet – 9M 2025 9M 2025 Results – Investors’ & Analysts’ Presentation 21
Slide 22: Market Overview- Critical Cost Factors
Market Overview- Critical Cost Factors Fuel cost trends remain stable; electricity at elevated levels. US Natural Gas (USD/Mmbtu) Coal API2 Index (USD/ton) PACE Index >50 HGI; 4.5% Sulfur (USD/MT) 6.00 200.00 200.00 5.00 175.00 150.00 4.00 150.00 3.00 125.00 100.00 2.00 100.00 50.00 1.00 75.00 0.00
Slide 23: Q3 Sales and Profitability per Region
Q3 Sales and Profitability per Region SALES USA GR & WE SEE EMED 600 600 600 600 -0.2% 400 376.6 -0.6 376.0 400 400 400 +16.1% +7.6% 200 200 200 200 -3.9% 109.2 17.5 126.7 107.7 8.2 115.9 68.0 -2.6 65.4 0 0 0 0 2024 Variance 2025 2024 Variance 2025 2024 Variance 2025 2024 Variance 2025 EBITDA USA GR
Slide 24: Disclaimer
Disclaimer By accessing this presentation, you acknowledge that you have read, understood and accepted the terms of this disclaimer. This presentation (“the Presentation”) has been prepared by Titan SA (the “Company” and together with its subsidiaries, “the Group”) is being provided for informationa